arrow
M

Marcin Protasiewicz

wrocław medical university
H指数:15
被引数:901

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Procalcitonin Levels in ICU Patients with SARS-CoV-2-Associated Viral Sepsis

SARS-CoV-2相关病毒性脓毒症ICU患者中降钙素原水平

2026-04-280
OAAI
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trial

经导管主动脉瓣植入术后永久起搏器植入的起搏器恢复:LANDMARK试验的亚组研究

2026-04-250
OAAI
Impact of iron deficiency on left ventricular noninvasive myocardial work indices in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

铁缺乏对接受经导管主动脉瓣植入术的严重主动脉瓣狭窄患者左心室非侵入性心肌工作指数的影响

2026-01-010
PRE
Procedural characteristics and outcomes of patients undergoing Impella-assisted high-risk percutaneous coronary interventions in the IMPELLA-PL registry

经Impella辅助的高危经皮冠状动脉介入治疗患者的程序特征和结局:IMPELLA-PL登记研究

2025-12-011
OAAI
Redo-Transcatheter Aortic Valve Implantation (Redo-TAVI)—Pilot Study from Multicentre Nationwide Registry

再次经导管主动脉瓣植入术(Redo-TAVI)——多中心国家登记研究的试点研究

2025-11-180
OAAI
One-year outcomes of novel balloon-expandable versus contemporary transcatheter heart valves in severe aortic stenosis: the LANDMARK trial

新型球囊扩张瓣膜与当代经导管心脏瓣膜治疗严重主动脉狭窄的一年结果:LANDMARK试验

JACC
IF0
2025-11-160
OAAI
Indexed Aortic Valve Calcium Volume by Computed Tomography Angiography in Patients With Aortic Stenosis

经计算机断层血管造影测量的主动脉狭窄患者主动脉瓣钙化体积指数

2025-10-250
OAAI
TCT-1221 ReTAVI Registry: Early Outcomes of Redo-TAVI with SAPIEN Platform in a Real-World Prospective Cohort

TCT-1221 ReTAVI 注册研究:真实世界前瞻性队列中采用 SAPIEN 平台进行二次 TAVI 的早期结果

JACC
IF0
2025-10-220
PRE
Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trial

Myval、Sapien和Evolut THV系列主动脉反流的定量视频密度测量评估:LANDMARK试验结果

2025-09-290
OAAI
Comparative 30-day echocardiographic outcomes of Myval vs. Sapien and Evolut THVs: insights from LANDMARK trial

Myval与Sapien和Evolut经导管心脏瓣膜在30天超声心动图结果比较:LANDMARK试验的见解

2025-09-011
OAAI
Short-and long-term outcomes of Impella-protected, high-risk, elective PCI in patients with multivessel coronary disease and low ejection fraction - Polish Impella Registry

Impella支持下高危择期经皮冠状动脉介入治疗(PCI)在多支血管冠状动脉疾病和低射血分数患者中的短期和长期结局——波兰Impella注册研究

2025-06-300
PRE
LANDMARK comparison of early outcomes of newer- generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial

新一代Myval经导管心脏瓣膜系列与当代瓣膜 (Sapien和Evolut) 在患有严重症状性主动脉瓣狭窄的真实个体中的早期结果的里程碑比较: 一项随机非劣效性试验

LANCET
IF88.5
2024-06-019
OAAI
Latest-iteration balloon- and self-expandable transcatheter valves for severe bicuspid aortic stenosis: the TRITON study
2023-11-018
PRE
Usefulness of the Veterans Health Administration COVID-19 (VACO) Index for Predicting Short-Term Mortality among Patients of the COLOS Study
2023-09-281
OAAI